SCHEMBL7985495

SCHEMBL7985495

CCC(=O)Nc1ncn(Cc2cc(C)cc(C)c2)c1C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
FGFR1 P11362 1/20 0.38
FGFR4 P22455 1/20 0.38
KMT2A Q03164 3/20 0.37
MAPK8 P45983 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.34
RECQL P46063 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
P2RY14 Q15391 1/20 0.34
RPS6KB1 P23443 1/20 0.33
PARP10 Q53GL7 1/20 0.33
POLB P06746 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987961 0.89 MAPT (0.47) CYP11B1CYP11B2KMT2AMAPK8MAPT
SCHEMBL7973987 0.88 FGFR1 (0.45) CYP11B1CYP11B2FGFR1FGFR4KMT2A
SCHEMBL7991565 0.84 TSHR (0.49) FGFR1FGFR4KMT2ATSHRHSD17B10
SCHEMBL7991814 0.83 HSP90AA1 (0.44) KMT2AMAPTMEN1SMN1; SMN2POLB
SCHEMBL7974324 0.81 TNF (0.44) KMT2AMAPTTSHRMEN1HSD17B10
SCHEMBL7985508 0.81 ALDH1A1 (0.43) KMT2AMEN1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL7987598 0.81 RIOK2 (0.41) FGFR1FGFR4KMT2AMAPK8MEN1
SCHEMBL7985670 0.81 CDK9 (0.42) KMT2AMAPK8MAPTYTHDC1LMNA
SCHEMBL7974162 0.81 KDM4E (0.52) FGFR1FGFR4KMT2AMAPTSMN1; SMN2
SCHEMBL7988382 0.80 KMT2A (0.41) KMT2ATSHRMEN1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed